NCT06384729 Effectiveness of the EXOPULSE Mollii Ⓡ Suit in Patients With Multiple Sclerosis Status COMPLETED Phase NA
NCT06384716 Evaluation of the Influence of a Core Muscle Control-Based Rehabilitation Program Patients With Multiple Sclerosis Status RECRUITING Phase NA
NCT06381440 Traditional Versus Progressive Robot-assisted Gait Training in People With Multiple Sclerosis and Severe Gait Disability Status RECRUITING Phase NA
NCT06374108 Resistance Training and Corticospinal Excitability in Multiple Sclerosis Status RECRUITING Phase NA
NCT06372977 Kappa Index Versus Csf Oligoclonal Bands in Diagnosis of ms and Prediction of Disease Activity Status NOT_YET_RECRUITING Phase N/A
NCT06370403 Effects of Head and Neck Cooling and Heating on Fatigue in Multiple Sclerosis and Healthy Men Status COMPLETED Phase NA
NCT06360861 Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT06355804 Lifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase NA
NCT06346704 Prospective Longitudinal Monocentric Study to Evaluate the Syde® Digital Endpoint in Patients With Multiple Sclerosis Status TERMINATED Phase N/A
NCT06343558 Gait and Balance Impairment in Rare and Very Rare Neurological Diseases Status RECRUITING Phase N/A
NCT06337903 Self-compassion for People with Multiple Sclerosis: an Exploratory Feasibility Study Status NOT_YET_RECRUITING Phase NA
NCT06334094 Assessing the Cognitive Benefits of Ozanimod and Their Brain-Biomarkers in MS Status WITHDRAWN Phase PHASE4
NCT06330298 Improving Social Cognition and Social Behaviour in Various Brain Disorders Status RECRUITING Phase NA
NCT06330077 Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis Status NOT_YET_RECRUITING Phase PHASE2
NCT06329414 Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis Status RECRUITING Phase N/A
NCT06327789 Trunk Control and Disability in Persons With Multiple Sclerosis Status COMPLETED Phase N/A
NCT06322342 Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent Status COMPLETED Phase PHASE2